Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the rapid expansion is under scrutiny amid cost pressures, and the new CEO is ...

Mounjaro (tirzepatide) : Lilly's dual GIP/GLP-1 agonist has delivered best-in-class weight loss and glycemic control in T2D and, under its obesity brand Zepbound , has outperformed semaglutide in head ...

Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 percent ...

Ozempic has made its manufacturer, Novo Nordisk, Europe’s most valuable company, and has gone from Hollywood’s “dirty little secret” to a status symbol among those no longer forced to suffer the ...

Novo Nordisk AS (NVO): Wegovy and Ozempic maker Novo Nordisk has frozen hiring in non-critical areas. Shares edged 0.3% up ...

Families of children at Camp Mystic who died in the devastating floods in Texas last month made emotional testimonies and ...